Navigation Links
Sigma-Aldrich Announces Q4 2012 Earnings Conference Call

ST. LOUIS, Jan. 23, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) will hold its quarterly conference call to discuss fourth quarter and full-year 2012 results on Thursday, February 7, 2013, at 11:00 AM Eastern Time.

Conference call details:
Date: February 7, 2013
Time: 11:00 AM ET

Listen via Internet:
Telephone: 877-266-0483
International: 707-287-9342

A replay of the call will be available from 2/07/2013 to 2/14/2013. For replay, please call: Domestic: 855-859-2056 International: 404-537-3406; Conference ID#: 93187749.

About Sigma-Aldrich:  Sigma-Aldrich is a leading Life Science and High Technology company.  Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing.  The Company has customers in life science companies, university and government institutions, hospitals and industry.  Over one million scientists and technologists use its products.  Sigma-Aldrich operates in 38 countries and has 9,000 employees providing excellent service worldwide.  The Company is committed to accelerating customer success through innovation and leadership in Life Science, High Technology and Service.  For more information about Sigma-Aldrich, please visit its award winning web site at


SOURCE Sigma-Aldrich Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Sigma-Aldrich Elects Michael Marberry As Director
2. Sigma-Aldrich Corporation Announces New Credit Facility
3. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
4. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
5. Oramed Pharmaceuticals Announces Reverse Stock Split
6. Kenrico Announces Records of Patents for 2012 and Financial Targets for 2013
7. Cato Research and Cato BioVentures Announces the Opening of Houston, Texas, Office
8. PharmaDirections Announces Appointment of Dr. Bruce Rehlaender as Principal, Formulation Development
9. NSG Announces New Quartz Micro Flow Channel
10. Amgen Announces Webcast of 2012 Fourth Quarter and Full Year Financial Results
11. Inflamax Research announces the launch of its Mobile Environmental Exposure Chamber™ for conduct of Allergy & Asthma Trials
Post Your Comments:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... in Vilnius, Lithuania, announced today that they have entered into a multiyear collaboration ... to provide CRISPR researchers with additional tools for gene editing across all applications. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, ... in analytical testing are being attributed to new regulatory requirements for all new ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... will be hosting a Webinar titled, “Pathology is going digital. Is your lab ... digital pathology adoption best practices and how Proscia improves lab economics and realizes ...
Breaking Biology Technology:
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):